Immutep (ASX:IMM) Share Price and News - StockTrack

Market Cap (1-Jul) $363,897,504 (530th)	Close (30-Jun) $0.315 0 (0%)	Volume (30-Jun) 2,012,212	Shortsold (19-Jun) 27,150,697 (1.86%) (138th)
52w High $0.415	52w Low $0.223	P/E 7.50	EPS -0.03

	Subject
	IMM IMM Ann: Change in substantial holding
	1 (current) 2 3
	IMM IMM Ann: Completion of Share Purchase Plan
	IMM IMM Ann: EGM - Now to be Held as an Online Virtual Meeting
	IMM IMM Ann: Immutep Quarterly Activities Report & Appendix 4C
	IMM IMM Ann: US FDA & IRB approves start of ph2b head & neck cancer trial
	IMM IMM Ann: Proposed issue of securities - IMM
	IMM IMM Ann: Change in substantial holding from AEF
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Cleansing Notice
	IMM IMM Ann: Notice of Extraordinary General Meeting/Proxy Form
	IMM IMM Ann: Share Purchase Plan Offer Documents
	IMM IMM Ann: Application for quotation of securities - IMM
	IMM IMM Ann: Efti to be evaluated in new triple combination therapy trial
	IMM IMM Ann: Proposed issue of securities - IMM
	IMM IMM Ann: Immutep Capital Raising Presentation
	IMM IMM Ann: Immutep secures commitments for A$60 million in a Placement
	IMM IMM Article: Immutep drafts in Bell Potter, Jefferies for raising
	IMM IMM Ann: Trading Halt
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Immutep global webcast slides
	IMM IMM Ann: Appendix 2A
	IMM IMM Ann: Immutep Reveals a New anti-LAG-3 Research Program
	IMM IMM Ann: Application for quotation of securities - IMM
	IMM IMM Article: Investors buoyed by positive data for Immutep’s immunotherapy
	IMM IMM Ann: Immutep presentation for Jefferies Healthcare Conference
	IMM IMM Ann: Immutep Reports Positive Data from its TACTI-002 ph 2 trial
	IMM IMM Ann: Immutep Reports Positive Final Data from INSIGHT-004 trial
	IMM IMM Ann: Immutep granted European patent for its LAG-3 candidate Efti
	IMM IMM Ann: Immutep enters New Collaboration with Merck KGaA for Efti
	IMM IMM Ann: Immutep granted Chinese patent for its LAG-3 candidate Efti
	IMM IMM Ann: Immutep to present at Jefferies Healthcare Conference
	IMM IMM Ann: TACTI-002 and INSIGHT-004 abstracts for ASCO 2021
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Appendix 2A
	IMM IMM Ann: Immutep Corporate Presentation
	IMM IMM Ann: Operational Update
	IMM IMM Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO
	IMM IMM Ann: Immutep Quarterly Activities Report & Appendix 4C
	IMM IMM Ann: Immutep receives A$1,155,055 R&D Tax Incentive
	IMM IMM Ann: Immutep Investor Update
	IMM IMM Ann: Immutep achieves Fast Track designation for Efti from US FDA
	IMM IMM Ann: Immutep announces European Patent Grant for LAG525
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Appendix 2A
	IMM IMM Article: Small cap biotech Immutep soars 10.5pc on Merck deal
	IMM IMM Ann: Immutep collaborates with MSD for phase 2b head & neck trial
	IMM IMM Ann: S&P DJI Announces March 2021 Quarterly Rebalance
	IMM IMM Ann: Immutep secures second US patent grant for eftilagimod alpha
	IMM IMM Ann: Immutep expands Part B of TACTI-002 collaboration trial

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.24	2,317,965	0.00 (0.00%)
27-Jun	$0.24	3,596,443	-0.01 (2.04%)
26-Jun	$0.25	9,618,322	+0.02 (6.52%)
24-Jun	$0.23	1,654,877	+0.01 (2.22%)
23-Jun	$0.23	2,623,915	-0.01 (4.26%)
20-Jun	$0.24	1,559,723	0.00 (0.00%)
19-Jun	$0.24	1,515,472	-0.01 (2.08%)
18-Jun	$0.24	3,258,168	-0.01 (2.04%)
16-Jun	$0.25	1,410,792	-0.01 (3.92%)
13-Jun	$0.26	2,467,998	0.00 (0.00%)
12-Jun	$0.26	6,583,523	-0.02 (5.56%)
06-Jun	$0.27	1,031,469	0.00 (0.00%)
05-Jun	$0.27	1,321,412	-0.01 (1.82%)
04-Jun	$0.28	1,790,793	0.00 (0.00%)
03-Jun	$0.28	383,083	-0.01 (1.79%)
2 up, 8 down, and 5 flat days

High $0.32	Low $0.30	Trades 243	Turnover $627,825	Volume 2,012,212
30 June 2023 at 4:10pm

High $0.32	Low $0.30	Trades 243	Turnover $627,825	Volume 2,012,212
30 June 2023 at 4:10pm

Immutep Health Care
Cancer Pharmaceuticals

$0.315 0.010 (3.28%)

$0.315 0.010 (3.28%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

IMM Immutep Health Care Cancer Pharmaceuticals

$0.315 0.010 (3.28%)

$0.315 0.010 (3.28%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Immutep Health Care
Cancer Pharmaceuticals